• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Diseases & Conditions

  • All Diseases and Conditions

The following clinical trials are associated with All diseases and conditions.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next
  • expand A Randomised, Double-blind, Parallel-group, Multicentre, Phase III Study to Compare the Efficacy and Tolerability of Fulvestrant (FASLODEX) 500 mg With Anastrozole (ARIMIDEX) 1 mg as Hormonal Treatment for Postmenopausal Women With Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer Who Have Not Previously Been Treated With Any Hormonal Therapy.
    Study Id
    D699BC00001
    Disease
    breast cancer
    Drug Name
    AstraZeneca Oncology and Infection Brands, Faslodex
    Study Name
    (FALCON)
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Collection of efficacy and safety data of chinese patients who have received Faslodex 250mg treatmen
    Study Id
    NIS-OCN-FAS-2011/1
    Disease
    breast cancer
    Drug Name
    Faslodex
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase I/Ib, Multicentre, Study Comprising a Safety Run-In of AZD5363 When Combined With Paclitaxel in Patients With Advanced or Metastatic Breast Cancer; Followed by a Randomised Expansion of AZD5363 When Combined With Paclitaxel vs. Paclitaxel Plus Placebo in Patients With Estrogen Receptor (ER)-Positive Advanced or Metastatic Breast Cancer, Stratified by Phosphoinositide-3-kinase (PIK3CA) Mutation Status.
    Study Id
    D3610C00002
    Study Name
    D3610C00002
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A non- interventional study to observe real life usage of atypical antipsychotics in the acute inpatient management of schizophrenia.
    Study Id
    NIS-NME-XXX-2011/1
    Disease
    schizophrenia
    Drug Name
    non drug study (neuroscience)
    Study Name
    RECONNECT-S BETA
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Ascending Inhaled Doses of AZD7594 in Healthy Male Volunteers
    Study Id
    D3740C00001
    Disease
    pharmacokinetics
    Study Name
    D3740C00001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand OPtimal Type 2 dIabetes Management Including benchmarking and Standard treatment in CEEMEA
    Study Id
    NIS-CME-XXX-2012/1
    Disease
    diabetes type 2
    Study Name
    OPTIMISE
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Nexium capsules Hp Specific Clinical Experience Investigation
    Study Id
    D961HC00011
    Disease
    gastrointestinal diseases
    Drug Name
    Nexium
    Study Name
    D961HC00011
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand (OSKIRA-Asia-1X): A Long-term Study to Assess the Safety of Fostamatinib in the Treatment of Rheumatoid Arthritis in Asia
    Study Id
    D4300C00029
    Disease
    rheumatoid arthritis
    Drug Name
    Fostamatinib Disodium
    Study Name
    D4300C00029
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase I, Open-label, Multicentre, Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AZD2014 Administered Orally in Combination With Intramuscular (IM) Fulvestrant to Patients With Estrogen Receptor Positive (ER+) Advanced, Metastatic Breast Cancer.
    Study Id
    D2270C00005
    Disease
    advanced breast cancer
    Study Name
    D2270C00005
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand European Real Life Study on NSAIDs Treated Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS): Assessment of Pain Relieve, Gastrointestinal (GI) Symptoms, Adherence and Health Resource Consumption
    Study Id
    NIS-GEU-DUM-2010/1
    Disease
    osteoarthritis
    Drug Name
    non drug study (gastrointestinal)
    Study Name
    NIS-GEU-DUM-2010/1
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report
    Aug 3, 2012
    • NIS-GEU-DUM-2010-1.pdf (500 KB)
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013